| Title |
Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy
|
|---|---|
| Published in |
JACC: CardioOncology, December 2019
|
| DOI | 10.1016/j.jaccao.2019.11.006 |
| Pubmed ID | |
| Authors |
Kent Y. Feng, Rahul S. Loungani, Vishal N. Rao, Chetan B. Patel, Michel G. Khouri, G. Michael Felker, Adam D. DeVore |
X Demographics
The data shown below were collected from the profiles of 98 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 22 | 22% |
| Spain | 8 | 8% |
| Argentina | 4 | 4% |
| Germany | 4 | 4% |
| Colombia | 3 | 3% |
| Mexico | 3 | 3% |
| United Kingdom | 3 | 3% |
| Russia | 3 | 3% |
| Italy | 2 | 2% |
| Other | 13 | 13% |
| Unknown | 33 | 34% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 62 | 63% |
| Practitioners (doctors, other healthcare professionals) | 19 | 19% |
| Scientists | 11 | 11% |
| Science communicators (journalists, bloggers, editors) | 6 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 38 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 9 | 24% |
| Student > Postgraduate | 4 | 11% |
| Researcher | 4 | 11% |
| Student > Doctoral Student | 2 | 5% |
| Student > Master | 2 | 5% |
| Other | 5 | 13% |
| Unknown | 12 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 42% |
| Agricultural and Biological Sciences | 2 | 5% |
| Engineering | 2 | 5% |
| Social Sciences | 2 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Other | 3 | 8% |
| Unknown | 12 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 55. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2020.
All research outputs
#783,902
of 25,591,967 outputs
Outputs from JACC: CardioOncology
#61
of 468 outputs
Outputs of similar age
#18,508
of 466,028 outputs
Outputs of similar age from JACC: CardioOncology
#3
of 30 outputs
Altmetric has tracked 25,591,967 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 468 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 466,028 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.